Akebia Therapeutics Inc (AKBA)
1.86
-0.06
(-3.12%)
USD |
NASDAQ |
Nov 14, 16:00
1.865
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Gross Profit (Annual): 120.47M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 120.47M |
| December 31, 2022 | 206.92M |
| December 31, 2021 | 60.98M |
| December 31, 2020 | -1.833M |
| Date | Value |
|---|---|
| December 31, 2019 | 189.66M |
| December 31, 2018 | 199.97M |
| December 31, 2017 | 181.23M |
| December 31, 2016 | 1.535M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
-1.833M
Minimum
2020
206.92M
Maximum
2022
115.24M
Average
120.47M
Median
2023
Gross Profit (Annual) Benchmarks
| Corcept Therapeutics Inc | 475.89M |
| Bioventus Inc | 328.19M |
| Eli Lilly and Co | 27.04B |
| NovaBay Pharmaceuticals Inc | 7.895M |
| Palatin Technologies Inc | 4.392M |